Myopia Completed Phase 1 Trials for Atropine (DB00572)

Also known as: Short-sighted / Short sightedness / Nearsighted

IndicationStatusPhase
DBCOND0009460 (Myopia)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03690414Evaluation of Short Term Use of Experimental Eye Drops BHVI2, 0.02% Atropine and BHVI2 Plus 0.02% Atropine Eye DropsOther
NCT03699423Effects of Low Concentration Atropine on Pupillary Size and Accommodative AmplitudeSupportive Care
NCT00457717Myopia Control by Combining Auricular Acupoint and Atropine EyedropsTreatment